Evaluation of intravenous amoxicillin-clavulanate use in two Canadian hospitals
We describe our experience with intravenous amoxicillin-clavulanate, which is new to the Canadian market. The majority of patients were successfully de-escalated from piperacillin-tazobactam or a carbapenem for respiratory infections or skin and soft tissue infections. Intravenous amoxicillin-clavul...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2024-01-01
|
Series: | Antimicrobial Stewardship & Healthcare Epidemiology |
Online Access: | https://www.cambridge.org/core/product/identifier/S2732494X24000184/type/journal_article |